Akero Therapeutics, Inc. (AKRO)
54.65
0.00 (0.00%)
USD |
NASDAQ |
Dec 09, 16:00
Akero Therapeutics Shareholders Equity (Quarterly): 957.64M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 92.80B |
| Eli Lilly & Co. | 23.79B |
| Bristol Myers Squibb Co. | 18.55B |
| Adaptive Biotechnologies Corp. | 204.44M |
| Johnson & Johnson | 79.28B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.006B |
| Total Liabilities (Quarterly) | 47.94M |
| Debt to Equity Ratio | 0.0012 |
| Current Ratio | 15.83 |
| Net Debt Paydown Yield | 0.18% |